However, in special cases such as triple-negative breast cancer (TNBC), which is defined by a tumor that lacks expression of ER, PR, and HER2, therapeutic targets are lacking, and the cancer shows aggressive clinical behavior[3]. This evidence concerns the gene ERBB2 and neoplasm.